Novartis Wins OK On $175M Deal To End Bias Action
A federal judge signed off Tuesday on a settlement valued at $175 million that ends a six-year-old sex bias class action against Novartis Pharmaceuticals Corp. fought on behalf of thousands of...To view the full article, register now.
Already a subscriber? Click here to view full article